ReproUnion
Reproductive Medicine Across BordersInfertility is a common chronic disease in the age group 20-45 years, affecting one in four Nordic couples. In the future, even more are expected to suffer from infertility due to factors such as age, lifestyle, and environmental exposures. Projections show that due to an increased demand for fertility treatments the industry is expected to grow by approx. 16% globally between 2020-2027.
During 15 years, ReproUnion has been driving collaboration across borders and disciplines between academia, hospitals, and industry. Our aim is to understand the underlying reasons of infertility and to personalise and improve reproductive treatment. To do so, ReproUnion is building an innovation platform to help the industry gain access to cutting-edge expertise and research infrastructure. Our new entrepreneurial setting is also inspiring the utilization of public research in patents and future spin-outs.
News
Find out what’s going on & stay up to date
ReproUnion Innovation Workshop: Transforming research into life-changing solutions
The ReproUnion Innovation Platform facilitated its first workshop to explore how cutting-edge research can be transformed into impactful, market-ready solutions. Innovation experts stories of successful research entrepreneurs and explained how to navigate differences in intellectual property (IP) rights in cross-border projects.
SEK 4.2 million grant to explore the impact of daily exposure to hormone-disrupting chemicals on fertility outcomes
The funding from the Swedish Research Council will enable the research team to use the ReproUnion Biobank and Infertility Cohort (RUBIC) to analyze data from more than 500 couples across Denmark and Sweden, including a broad panel of hormone-disrupting chemicals, vitamins, and other biomarkers.
MVA Summit features RUBIC: The golden egg in women’s and men’s fertility research
At the Medicon Valley Alliance Summit ReproUnion presented how research using the cross-border biobank can bring us closer to understand the reasons for infertility, while underlining the importance of the couple-centric approach, which makes RUBIC a true pioneer in this field.
